An investigation of the adsorption of hydroxypropylmethyl cellulose 2910 5 mPa s and polyvinylpyrrolidone K90 around Naproxen nanocrystals

Journal of Pharmaceutical Sciences

Volumn 101, Issue 10, 2012, Pages 3916-3923

  Kayaert, Pieterjan ^a   Van den Mooter, Guy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Calorimetry (DSC); Drying; HPMC; Nanoparticles; Nanosuspensions; Nanotechnology; Polymers; PVP; Solubility; Stabilization

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; NANOCRYSTAL; NAPROXEN; POVIDONE; STABILIZING AGENT;

ADSORPTION; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; GLASS TRANSITION TEMPERATURE; PHYSICAL CHEMISTRY; SURFACE PROPERTY; SUSPENSION;

EID: 84865378007     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23267     Document Type: Article

References (15)

1. Van Eerdenbrugh B, Van den Mooter G, Augustijns P. 2008. Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64-75.
2. Kipp JE. 2004. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 284:109-122.
3. Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785-796.
4. Merisko-Liversidge E, Liversidge GG, Cooper ER. 2003. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 18:113-120.
5. Lee J, Choi J-Y, Park CH. 2008. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm 355:328-336.
6. Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, Van den Mooter G. 2009. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci 98:2091-2103.
7. Kesisoglou F, Panmai S, Wu Y. 2007. Nanosizing-Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631-644.
8. Deng J, Huang L, Liu F. 2010. Understanding the structure and stability of paclitaxel nanocrystals. Int J Pharm 390:242-249.
9. Kayaert P, Van den Mooter G. 2012. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine. Eur J Pharm Biopharm 81: 650-656. [Epub ahead of print].
10. Pérez OE, Sanchez CC, Pilosof AMR, Patino JMR. 2006. Dynamics of adsorption of hydroxypropyl methylcellulose at the air-water interface. Food Hydrocolloid 22:387-402.
11. Hirai H, Yakura N. Protecting polymers in suspension of metal nanoparticles. Polym Adv Technol 12:724-733.
12. Wu L, Zhang J, Watanabe W. 2011. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 63:456-469.
13. Yeager JD, Dubey M, Wolverton MJ, Jablin MS, Majewski J, Bahr DF, Hooks DE. 2011. Examining chemical structure at the interface between a polymer binder and a pharmaceutical crystal with neutron reflectometry. Polymer 52(17):3762-3768.
14. Kayaert P, Anné M, Van den Mooter G. 2011. Bead layering as a process to stabilize nanosuspensions: Influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads. J Pharm Pharmacol 63:1446-1453.
15. Verma S, Huey BD, Burgess DJ. 2011. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir 25:12481-12487.